Scilex Holding (SCLX) Operating Expenses (2020 - 2026)
Scilex Holding (SCLX) posted Operating Expenses of $37.1 million for Q2 2026, down 9.11% on a QoQ basis from $40.8 million in Q1 2026, and up 21.91% year-over-year from $30.4 million in Q2 2025.
Analysis
Scilex Holding (SCLX) Operating Expenses (2020 - 2026) Analysis & Trends
Scilex Holding has reported Operating Expenses for 7 years, with the latest figure at $37.1 million in Q2 2026.
- On a quarterly basis, Operating Expenses rose 21.91% year-over-year to $37.1 million in Q2 2026; TTM through Jun 2026 was $390.8 million, a 177.29% increase from a year earlier, with the FY2025 full-year figure at $376.3 million, up 168.78% from the prior year.
- Operating Expenses was $37.1 million for Q2 2026 at Scilex Holding, down from $40.8 million in the prior quarter.
- The five-year high for Operating Expenses was $197.1 million in Q3 2025, with the low at $15.6 million in Q1 2022.
- Average Operating Expenses over 5 years is $46.4 million, with a median of $33.6 million recorded in 2024.
- The largest YoY upside for Operating Expenses was 11168.15% in 2022 against a maximum downside of 52.42% in 2022.
- Over 5 years, Operating Expenses stood at $31.7 million in 2022, then advanced by 0.45% to $31.8 million in 2023, then soared by 36.09% to $43.3 million in 2024, then surged by 167.76% to $115.9 million in 2025, then plunged by 68.02% to $37.1 million in 2026.
- The last three Operating Expenses figures came in at $37.1 million (Q2 2026), $40.8 million (Q1 2026), and $115.9 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | 10.12 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | 10.56 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | 12.80 Bn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | -6.09 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 6.68 Bn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | -5.98 Bn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | 505.13 Mn |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | 976.14 Mn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | 452.50 Mn |
| 10 | Scilex Holding | 35.91 Mn | -76.88 Mn | 3.97 Mn | 37.07 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 37.07 Mn |
| Mar 31, 2026 | 40.78 Mn |
| Dec 31, 2025 | 115.88 Mn |
| Sep 30, 2025 | 197.07 Mn |
| Jun 30, 2025 | 30.40 Mn |
| Mar 31, 2025 | 32.90 Mn |
| Dec 31, 2024 | 43.28 Mn |
| Sep 30, 2024 | 34.35 Mn |
| Jun 30, 2024 | 31.99 Mn |
| Mar 31, 2024 | 30.36 Mn |
| Dec 31, 2023 | 31.80 Mn |
| Sep 30, 2023 | 48.92 Mn |
| Jun 30, 2023 | 35.40 Mn |
| Mar 31, 2023 | 36.06 Mn |
| Dec 31, 2022 | 31.66 Mn |
| Sep 30, 2022 | 21.99 Mn |
| Jun 30, 2022 | 19.40 Mn |
| Mar 31, 2022 | 15.62 Mn |
| Dec 31, 2021 | 66.53 Mn |
| Sep 30, 2021 | 283,346.00 |